This website uses cookies
Read our Privacy policy and Terms of use for more information.
May 21, 2026
BMS deploys Claude across 30,000 employees, Lilly files a bizarre rebate fraud lawsuit, and Takeda faces a landmark legal blow.
May 19, 2026
Revolution Medicines is drawing “next oncology titan” comparisons, pharma tariff exemptions get complicated, and FDA chaos continues.
May 14, 2026
Big Pharma is absent from Trump’s China trip, Novo drops fresh obesity data, and FDA Commissioner Marty Makary exits.
May 12, 2026
Moderna shares jump on hantavirus vaccine headlines, Gilead eyes $1B Yeztugo forecast, an Italian pharma's $4B purchase, and biotech layoffs keep piling up.
May 7, 2026
Zuckerberg drops $500M on AI biology, Novo’s Wegovy pill surprises Wall Street, and Lilly keeps building a pharma fortress.
May 5, 2026
Obesity overtakes oncology in pipeline value, Novo’s pill is rewriting the GLP-1 race, and Lilly keeps printing cash.
Apr 30, 2026
George Church’s Rejuvenate Bio launches a crowdfunding campaign for gene therapy, meanwhile the FDA pilots real-time clinical trial data to speed drug development.
Apr 28, 2026
The entire NSF board gets fired, Lilly's latest deal, and a gene therapy helps children hear for the first time.
Apr 23, 2026
Big Pharma is going full AI mode... and Merck just dropped $1B to prove it.
